Shares of WUXI APPTEC, a leading pharmaceutical services company, soared 7.08% on Monday morning, driven by increased buying interest from a major institutional investor.

According to the Hong Kong Stock Exchange, Swiss banking giant UBS Group increased its long position, or stake, in WUXI APPTEC's H-shares to 5.22% as of November 6th, up from 4.50% previously. This move by UBS signals growing confidence in the company's prospects and has likely contributed to the surge in WUXI APPTEC's stock price.

The increase in UBS's stake comes as WUXI APPTEC continues to expand its global footprint and service offerings, positioning itself as a key player in the rapidly growing pharmaceutical and biotechnology sectors. Investors appear to be betting on the company's ability to capitalize on the growing demand for its services and deliver strong financial performance in the coming years.